We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Albemarle (ALB) Stock Moves -0.63%: What You Should Know
Read MoreHide Full Article
In the latest trading session, Albemarle (ALB - Free Report) closed at $227.57, marking a -0.63% move from the previous day. This move was narrower than the S&P 500's daily loss of 0.79%. At the same time, the Dow lost 1.07%, and the tech-heavy Nasdaq lost 2.71%.
Heading into today, shares of the specialty chemicals company had gained 4.66% over the past month, outpacing the Basic Materials sector's gain of 1.43% and the S&P 500's gain of 4.16% in that time.
Investors will be hoping for strength from Albemarle as it approaches its next earnings release. On that day, Albemarle is projected to report earnings of $4.29 per share, which would represent year-over-year growth of 24.35%. Meanwhile, our latest consensus estimate is calling for revenue of $2.56 billion, up 73.3% from the prior-year quarter.
For the full year, our Zacks Consensus Estimates are projecting earnings of $23.12 per share and revenue of $10.35 billion, which would represent changes of +5.28% and +41.38%, respectively, from the prior year.
Any recent changes to analyst estimates for Albemarle should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection has moved 1.51% higher. Albemarle is currently a Zacks Rank #3 (Hold).
In terms of valuation, Albemarle is currently trading at a Forward P/E ratio of 9.91. This represents a discount compared to its industry's average Forward P/E of 14.43.
Investors should also note that ALB has a PEG ratio of 0.62 right now. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. Chemical - Diversified stocks are, on average, holding a PEG ratio of 1.37 based on yesterday's closing prices.
The Chemical - Diversified industry is part of the Basic Materials sector. This industry currently has a Zacks Industry Rank of 170, which puts it in the bottom 33% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Albemarle (ALB) Stock Moves -0.63%: What You Should Know
In the latest trading session, Albemarle (ALB - Free Report) closed at $227.57, marking a -0.63% move from the previous day. This move was narrower than the S&P 500's daily loss of 0.79%. At the same time, the Dow lost 1.07%, and the tech-heavy Nasdaq lost 2.71%.
Heading into today, shares of the specialty chemicals company had gained 4.66% over the past month, outpacing the Basic Materials sector's gain of 1.43% and the S&P 500's gain of 4.16% in that time.
Investors will be hoping for strength from Albemarle as it approaches its next earnings release. On that day, Albemarle is projected to report earnings of $4.29 per share, which would represent year-over-year growth of 24.35%. Meanwhile, our latest consensus estimate is calling for revenue of $2.56 billion, up 73.3% from the prior-year quarter.
For the full year, our Zacks Consensus Estimates are projecting earnings of $23.12 per share and revenue of $10.35 billion, which would represent changes of +5.28% and +41.38%, respectively, from the prior year.
Any recent changes to analyst estimates for Albemarle should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.
Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection has moved 1.51% higher. Albemarle is currently a Zacks Rank #3 (Hold).
In terms of valuation, Albemarle is currently trading at a Forward P/E ratio of 9.91. This represents a discount compared to its industry's average Forward P/E of 14.43.
Investors should also note that ALB has a PEG ratio of 0.62 right now. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. Chemical - Diversified stocks are, on average, holding a PEG ratio of 1.37 based on yesterday's closing prices.
The Chemical - Diversified industry is part of the Basic Materials sector. This industry currently has a Zacks Industry Rank of 170, which puts it in the bottom 33% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.